News Releases

2020-03/25
United BioPharma Received Approval from China NMPA for a Phase 1 Trial with UB-221 in Healthy Volunteers
1
2020-03/24
United BioPharma Received Approval from China NMPA for a Phase 2 Trial to Evaluate the Reduction Effect of UB-421 mAb on Latent HIV Reservoirs in ART-stabilized HIV Patients
2
2020-03/19
San Miguel County orders residents to shelter in place before countywide coronavirus testing
3
2020-03/19
UBI 集團科研能量將攻堅新冠肺炎病毒帶來的人類大災難
4
2019-11/26
United BioPharma Signs clinical trial agreement with NIH/NIAID for sponsorship of a multi-drug resistant HIV trial with UB-421
5
2019-11/08
United BioPharma Receives US FDA Approval for UB-221 Phase 1 IND for Chronic Spontaneous Urticaria
6
2019-10/07
PharmaBoardRoom interview of Dr. Chang Yi Wang, Chairperson and Chief Scientific Officer of United Biopharma (UBP)
7
2019-09/02
United BioPharma successfully completes Taiwan FDA GMP inspection for its 2000L commercial scale manufacturing facility
8
2019-05/14
United BioPharma Receives China NMPA Approval for UB-421 Phase 3 ART-Substitution Trial in HIV-infected Patients
9
2020-03/25
United BioPharma Received Approval from China NMPA for a Phase 1 Trial with UB-221 in Healthy Volunteers
1
2020-03/24
United BioPharma Received Approval from China NMPA for a Phase 2 Trial to Evaluate the Reduction Effect of UB-421 mAb on Latent HIV Reservoirs in ART-stabilized HIV Patients
2
2020-03/19
San Miguel County orders residents to shelter in place before countywide coronavirus testing
3
2020-03/19
UBI 集團科研能量將攻堅新冠肺炎病毒帶來的人類大災難
4
2019-11/26
United BioPharma Signs clinical trial agreement with NIH/NIAID for sponsorship of a multi-drug resistant HIV trial with UB-421
5
2019-11/08
United BioPharma Receives US FDA Approval for UB-221 Phase 1 IND for Chronic Spontaneous Urticaria
6
2019-10/07
PharmaBoardRoom interview of Dr. Chang Yi Wang, Chairperson and Chief Scientific Officer of United Biopharma (UBP)
7
2019-09/02
United BioPharma successfully completes Taiwan FDA GMP inspection for its 2000L commercial scale manufacturing facility
8
2019-05/14
United BioPharma Receives China NMPA Approval for UB-421 Phase 3 ART-Substitution Trial in HIV-infected Patients
9